Hakutulokset - Andrea B. Apolo

Tarkenna hakua
  1. 1
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer Tekijä Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Targeted therapies in urothelial carcinoma

    Targeted therapies in urothelial carcinoma Tekijä Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal, Andrea B. Apolo

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Immunotherapy: a new treatment paradigm in bladder cancer

    Immunotherapy: a new treatment paradigm in bladder cancer Tekijä Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Trimodality Therapy in Bladder Cancer

    Trimodality Therapy in Bladder Cancer Tekijä Christopher Premo, Andrea B. Apolo, Piyush K. Agarwal, Deborah E. Citrin

    Julkaistu 2015
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Multimodal management of muscle-invasive bladder cancer

    Multimodal management of muscle-invasive bladder cancer Tekijä Jong‐Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss

    Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss Tekijä Bharath Ramaswamy, Soumen Roy, Andrea B. Apolo, Benjamin Shapiro, Didier A. Depireux

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review

    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review Tekijä Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

    Julkaistu 2021
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

    Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer Tekijä Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

    Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival Tekijä Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, S. Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L. Gulley

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Cabozantinib for the treatment of solid tumors: a systematic review

    Cabozantinib for the treatment of solid tumors: a systematic review Tekijä Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report

    Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report Tekijä Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, Andrea B. Apolo, Bharath Sathya, Andrew E. Arai, James L. Gulley, Marijo Bilušić

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib

    Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib Tekijä Rena C. Zuo, Andrea B. Apolo, John J. DiGiovanna, Howard L. Parnes, Corrine Keen, Swati Nanda, William L. Dahut, Edward W. Cowen

    Julkaistu 2014
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy

    Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy Tekijä Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer

    Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer Tekijä Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

    Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions Tekijä Nick G. Cowan, Yiyi Chen, Tracy M. Downs, Bernard H. Bochner, Andrea B. Apolo, Michael P. Porter, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy

    Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy Tekijä Soraya Alarcon, Mehdi Mollapour, M.-J. Lee, Shinji Tsutsumi, S. Lee, Y.S. Kim, Thomas L. Prince, Andrea B. Apolo, Giuseppe Giaccone, Wanping Xu, Len Neckers, Jane B. Trepel

    Julkaistu 2012
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer

    Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer Tekijä Arjun Vasant Balar, Andrea B. Apolo, Irina Ostrovnaya, Svetlana Mironov, Alexia Iasonos, A. Trout, Ashley Marie Regazzi, Ilana Garcia-Grossman, David Gallagher, Matthew I. Milowsky, Dean F. Bajorin

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Advances in medical imaging for the diagnosis and management of common genitourinary cancers

    Advances in medical imaging for the diagnosis and management of common genitourinary cancers Tekijä Mohammadhadi Bagheri, Mark A. Ahlman, Liza Lindenberg, Barış Türkbey, Jeffrey Lin, A. Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les Folio, Andrea B. Apolo

    Julkaistu 2017
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial

    Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... Tekijä David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri

    Julkaistu 2022
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

    Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies Tekijä Carl Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo, Jung‐Min Lee, George N. Papaliodis, Shilpa Kodati, Rachel Bishop, M. Teresa Magone, Lucia Sobrin, H. Nida Sen

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: